National Centre for Pharmacoeconomics

National Centre for

NCPE Ireland

An economic evaluation of suboxone for the management of opiate addiction.

Pharmacoeconomic Evaluation

Commenced Completed Outcome
November 2007 Reimbursement not recommended.

Suboxone cannot be considered a cost effective option for patients attending HSE clinics or in the community setting in Ireland.

Suboxone summary


Pharmacoeconomic Reassessment

Commenced Completed Outcome
02/01/2014 22/05/2014 Reimbursement Not Recommended.

The NCPE does not consider Suboxone® to be cost-effective compared to methadone for the treatment of opioid dependence.

Suboxone Summary 2014